Cover Image
市場調查報告書

封閉式藥物轉移系統

Closed Drug Transfer Systems to 2020

出版商 Greystone Research Associates 商品編碼 135878
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
封閉式藥物轉移系統 Closed Drug Transfer Systems to 2020
出版日期: 2014年08月01日 內容資訊: 英文
簡介

認定對人類有害的藥物施給,為能明確理解該物質的危險性而詳查量增加。最前線治療領域為臨床腫瘤學,進行減輕暴露於細胞毒性醫藥品的嘗試。

本報告提供腫瘤的治療市場上細胞毒性醫藥品的影響與安全性調查分析、市場趨勢與人口動態、封閉式藥物轉移產品分析、需求推動因素、競爭要素驗證、主要企業、產品開發、商務策略等相關的系統性資訊。

摘要整理

細胞毒性醫藥品的治療市場趨勢

  • 治療趨勢與問題點
  • 注射型/點滴型抗癌藥物的施給
  • 醫藥品包裝和給藥技術
  • 封閉式藥物轉移市場推動因素
  • 競爭情形
  • 危險因素

封閉式藥物轉移的設計因素

  • 主要的系統設計因素
  • 人因工程/人體工學
  • 物質選擇的問題點
  • 藥物的重組與稀釋
  • 癌症治療藥的安全性
  • 癌症治療藥的給藥和用量
  • 各藥物的用量設定和個人的用量設定

封閉式藥物轉移 - 商用設備的評估與市場資料

  • ChemoCLAVE
  • EquaShield
  • OnGuard
  • PhaSeal
  • Texium/SmartSite
  • 其他封閉式藥物轉移設備

市場因素

  • 法規上的問題點
  • 看護者的適合性
  • 複雜的層級與易用性
  • 醫療經濟
  • 經營模式與策略

市場評估與預測

  • 北美
  • 歐洲
  • 亞洲
  • 其他地區市場

封閉式藥物轉移 - 市場參與企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KDT462F

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion. Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery

Highlights

  • Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics
  • Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs
  • Analyzes demand drivers and competitive factors influencing closed drug transfer adoption
  • Charts product data and provides forecasts to 2020
  • Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents

Summary of Contents

Executive Summary

Cytotoxic Drug Therapeutics Market Dynamics

  • Therapeutic Trends and Issues
  • The Administration of injectable/Infusible Antineoplastics
  • Drug Packaging and Administration Technology
  • Closed Drug Transfer Market Drivers
  • Competitive Landscape
  • Risk Factors

Closed Drug Transfer Design Factors

  • Key System Design Elements
  • Human Engineering/Ergonomics
  • Material Selection Issues
  • Drug Reconstitution and Dilution
  • Oncology Therapeutics Medication Safety
  • Oncology Drug Administration and Dosing
  • Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer - Commercial Device Assessments and Market Data

  • ChemoCLAVE
  • EquaShield
  • OnGuard
  • PhaSeal
  • Texium/SmartSite
  • Other Closed Drug Transfer Devices

Market Factors

  • Regulatory Issues
  • Caregiver Compliance
  • Level of Complexity and Ease of Use
  • Healthcare Economics
  • Business Models and Strategies

Market Assessments and Forecasts

  • North America
  • Europe
  • Asia
  • Other Geographic Markets

Closed Drug Transfer - Market Participant Profiles

Back to Top